Presentation DIVES MED AMI 100 stands out as a cutting-edge injectable solution dedicated to comprehensive facial rejuvenation. Relying on the unique properties of Polylactic Acid (PLLA), this medical device works deep within to revitalize the dermis. Rather than passively filling wrinkles, it triggers a natural tissue response that promotes neocollagenesis. This process ensures a gradual restoration of volume and a visible improvement in skin firmness over time.
Composition
& Rheology Active ingredient: Polylactic Acid (PLLA), a fully biocompatible and biodegradable polymer. Format: 5 ml injectable suspension containing rigorously calibrated microparticles. Technology: Optimized formulation integrating OBT technology.
Indications
This treatment is particularly indicated for managing moderate skin laxity and age-related volume loss. It effectively targets hollow cheeks, pronounced nasolabial folds, and marionette lines. It also helps redefine the facial oval while providing a natural and harmonious tightening effect without weighing down the features.
Storage The 5 ml vial should be stored at room temperature, away from direct sunlight and freezing conditions. Keep the product in its tightly closed original packaging until clinical preparation. Contraindications Pregnancy and breastfeeding periods. Presence of active infections or skin inflammation in the targeted area.
Known hypersensitivity to polylactic acid or any of the components. History of keloid scarring or healing disorders.
FAQ
How long does the treatment last? Once the initial clinical protocol is completed, the aesthetic benefits and natural lifting effect can be maintained for up to 24 months, depending on the patient's metabolism.
